KALA BIO, Inc. — Income Charts
4 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$4M
R&D
$18M
SG&A
$65M
D&A
$537K
Operating Income
$-82M
EBITDA
$-81M
Interest Expense
$7M
Interest Income
$664K
Tax Provision
$0
Net Income
$-45M
Operating Margin
-2099.3%
Net Margin
-1151.6%
DTA Valuation Allowance
$121M
Tax Credit Carryforwards
$0
NOL Carryforwards
$103M
ETR Federal Statutory
21.0%
ETR State + Local (pp)
5.4%
Operating Lease Cost
$414K
Revenue YoY Variation
-65.4%
Income YoY Variation
37.3%